Login / Signup

Efficiency of pooled surveillance testing in academic labs to detect and inhibit COVID-19 outbreaks.

John C SitkoJames Jordan SteelErin A AlmandChristopher A CullenbineJoseph W RohrerDouglas P WickertSteven Cm Hasstedt
Published in: Bioanalysis (2021)
Robust surveillance testing is a key strategic plan to prevent COVID-19 outbreaks and slow the spread of the SARS-CoV-2 pandemic; however, limited resources, facilities and time often impair the implementation of a widespread surveillance effort. To mitigate these resource limitations, we employed a strategy of pooling samples, reducing reagent cost and processing time. Through utilizing academic faculty and labs, successful pooled surveillance testing was conducted throughout Fall 2020 semester to detect positive SARS-CoV-2 infections in a population of 4400 students. During the semester, over 25,000 individual COVID status evaluations were made by pooling eight individual samples into one quantitative reverse transcription polymerase chain reaction. This pooled surveillance strategy was highly effective at detecting infection and significantly reduced financial burden and cost by $3.6 million.
Keyphrases
  • sars cov
  • public health
  • coronavirus disease
  • respiratory syndrome coronavirus
  • randomized controlled trial
  • transcription factor
  • risk factors
  • clinical trial
  • phase iii
  • health insurance